Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:704-709
doi: 10.1161/hy0202.103823
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muthalif, M. M.
Right arrow Articles by Malik, K. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muthalif, M. M.
Right arrow Articles by Malik, K. U.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Cell signalling/signal transduction
Right arrow Hypertension - basic studies
Right arrow Smooth muscle proliferation and differentiation

(Hypertension. 2002;39:704.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Functional Significance of Activation of Calcium/Calmodulin–Dependent Protein Kinase II in Angiotensin II–Induced Vascular Hyperplasia and Hypertension

Mubarack M. Muthalif; Nour A. Karzoun; Ibrahim F. Benter; Lillian Gaber; Farid Ljuca; Mohammed R. Uddin; Zinat Khandekar; Anne Estes; Kafait U. Malik

From the Department of Pharmacology and Vascular Biology, Center of Excellence, College of Medicine (M.M.M., N.A.K., I.F.B., M.R.U., Z.K., A.E., K.U.M.), and the Department of Pathology (L.G., F.L.), The University of Tennessee, Baptist Memorial Hospital, Memphis, Tenn.

Correspondence to Kafait U. Malik, PhD, DSc, Professor of Pharmacology, Department of Pharmacology, College of Medicine, The University of Tennessee, Memphis, TN 38163. E-mail kmalik{at}utmem.edu

We have reported that norepinephrine (NE) and angiotensin II (Ang II) increase CaM kinase II activity, which, in turn, activates cytosolic phospholipase A2 (PLA2) and releases arachidonic acid. The products of arachidonic acid generated via cytochrome P-450 and lipoxygenase contribute to the development of hypertension and vascular smooth muscle cell (VSMC) hyperplasia. The purpose of this study was to investigate whether CaM kinase II contributes to VSMC proliferation elicited by NE and Ang II and to hypertension induced by Ang II. NE (1 µmol/L) and Ang II (1 µmol/L) increased proliferation of rabbit aortic VSMC as measured by increased [3H]-thymidine incorporation; this effect of NE and Ang II was attenuated 88±10% and 64±11% by the CaM kinase II inhibitor KN-93, respectively. Infusion of Ang II with miniosmotic pumps (350 ng/min for 6 days) in rats elevated mean arterial pressure (MABP), which was reduced by simultaneous infusion of KN-93 (578 ng/min, for 6 days) (Ang II alone: MABP =174±3 mm Hg, n=12 versus Ang II + KN-93: MABP 123±5 mm Hg, n=4, P<0.05). Administration of KN-93 as a single bolus injection (16 mg/Kg), but not its vehicle, in Ang II–infused hypertensive animals also decreased MABP from 179±9 mm Hg to 109±6 mm Hg (n=5, P<0.05). CaM kinase II activity was increased in the kidney of Ang II–infused hypertensive animals compared with normotensive controls. Treatment with KN-93 reduced CaM kinase II activity and ameliorated the intravascular injury in the kidneys of Ang II–infused hypertensive rats. Our data indicate that CaM kinase activation represents an important component of the mechanism(s) initiating VSMC proliferation and the development and maintenance of Ang II–induced hypertension in rat.


Key Words: kinase • angiotensin II • hypertension, essential • muscle, smooth, vascular




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
Z. Pavicevic, C. C. Leslie, and K. U. Malik
cPLA2 phosphorylation at serine-515 and serine-505 is required for arachidonic acid release in vascular smooth muscle cells
J. Lipid Res., April 1, 2008; 49(4): 724 - 737.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Cai, D. Liu, and J. G.N. Garcia
CaM Kinase II-dependent pathophysiological signalling in endothelial cells
Cardiovasc Res, January 1, 2008; 77(1): 30 - 34.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. C. Sucharov, S. Langer, M. Bristow, and L. Leinwand
Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV/PKD and PP2A
Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1029 - C1037.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Sarkis, O. Ito, T. Mori, M. Kohzuki, S. Ito, J. Verbalis, A. W. Cowley Jr., and R. J. Roman
Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1333 - F1340.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Gerzanich, S. Ivanova, M. S. van der Heijden, H. Zhou, and J. M. Simard
Trans-Cellular Proliferating Cell Nuclear Antigen Gene Activation in Cerebral Vascular Smooth Muscle by Endothelial Oxidative Injury In Vivo
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2048 - 2054.
[Abstract] [Full Text] [PDF]